Can UCLA utilize a central IRB?
Certain Phase III & IV multi-center sponsor-initiated protocol clinical trials may be approved for review by the UCLA approved outside IRB. UCLA has strict terms and internal review for such approval and it is not at the sole discretion of the investigator or sponsor. Please note that if a study is submitted to the outside IRB and that IRB disapproves the study, that study cannot subsequently be submitted to any other UCLA IRB.